Separation And Release Agreement Sample Contracts

Chaparral Energy, Inc. – Separation and Release Agreement (February 15th, 2019)

This Separation and Release Agreement (this "Agreement") is by and between Chaparral Energy, LLC (the "Company"), Chaparral Energy, Inc. ("CEI"), and Joseph Evans (the "Individual").

Separation and Release Agreement (February 7th, 2019)

Tapestry, Inc. and its subsidiaries ("Employer") and Kevin Wills ("Executive") enter into this Separation and Release Agreement ("Agreement"), which was received by Executive on November 19, 2018, signed by Executive on the date shown below Executive's signature on the last page of this Agreement and is effective eight days (8) after the date of execution by Executive unless Executive revokes the agreement before that date, for and in consideration of the promises made among the parties and other good and valuable consideration as follows:

Federal Home Loan Bank of Indianapolis – Attachment a Separation and Release Agreement (January 29th, 2019)

This Separation and Release Agreement ("Agreement") is between Mary M. Kleiman ("Kleiman" or "Employee") and Federal Home Loan Bank of Indianapolis, its parent, subsidiary and affiliated companies or entities, all current and former officers, directors, employees, agents, attorneys and contractors for these companies, (herein collectively referred to as "FHLBI" or "Bank"). Kleiman and FHLBI are collectively referred to as the "Parties".

Guess – Separation and Release Agreement (January 28th, 2019)

This Separation and Release Agreement (this "Agreement") is made and entered into this 25th day of January 2019 (the "Effective Date"), by and between Guess?, Inc., a Delaware corporation (the "Company"), and Victor Herrero Amigo ("Executive").

Onconova Therapeutics Inc. – Separation and Release Agreement (January 15th, 2019)

This SEPARATION AND RELEASE AGREEMENT (this Agreement) is entered into as of January 15, 2019 to be effective on the Effective Date (as defined in Section 20(g) below), by and between Onconova Therapeutics, Inc. (the Company) and Ramesh Kumar, Ph.D. (the Executive).

Separation and Release Agreement (January 2nd, 2019)

This SEPARATION AND RELEASE AGREEMENT ("Separation Agreement") is made and entered into by and between Anne Martin-Vachon ("Employee") and the EVINE Live Inc., a Minnesota corporation (the "Company").

Separation and Release Agreement (December 7th, 2018)
Amendment to Separation and Release Agreement (December 4th, 2018)
Amendment to Separation and Release Agreement (December 4th, 2018)
Separation and Release Agreement (December 3rd, 2018)

This Separation and Release Agreement (the Agreement) between Virtusa Corporation (the Company or Virtusa) and Mr. Raj Rajgopal (Executive) and shall be effective as of the Effective Date (as defined below).

Severance Calculation Contingent on Receipt of a Signed Separation and Release Agreement (November 21st, 2018)

You must meet the following conditions in order to receive the severance, Cobra Subsidy/cash and outplacement (as outlined above):

Separation and Release Agreement (November 15th, 2018)

This Separation and Release Agreement ("Agreement") is made by and between Sanmina Corporation, for itself and on behalf of all its subsidiaries and affiliates, hereinafter referred to as the "Company," and Robert K. Eulau, hereinafter referred to as "Employee" and is dated as of September 14, 2018 (the "Effective Date").

Separation and Release Agreement (November 15th, 2018)

This Separation and Release Agreement ("Agreement") is made by and between Sanmina Corporation, for itself and on behalf of all its subsidiaries and affiliates, hereinafter referred to as the "Company," and Gerry Fay, hereinafter referred to as "Employee" and is dated as of September 14, 2018 (the "Effective Date").

Expo Event Holdco, Inc. – Separation and Release Agreement (November 14th, 2018)

This Separation and Release Agreement (this "Agreement") is entered into as of November 8, 2018 (the "Effective Date"), by and between David Loechner (the "Executive"), Emerald Expositions, LLC, a Delaware limited liability company (the "Company"), and solely for the purpose of Section 2(b), Emerald Expositions Events, Inc. ("Parent") (each of the Executive, the Company, and solely for the purpose of Section 2(b), Parent, a "Party" and collectively, the "Parties"). The Parties acknowledge that the terms and conditions of this Agreement have been voluntarily agreed to and are intended to be final and binding.

Gemphire Therapeutics Inc. – Separation and Release Agreement (November 8th, 2018)

THIS SEPARATION AND RELEASE AGREEMENT (this "Agreement") is made as of September 21, 2018 by and between GEMPHIRE THERAPEUTICS INC., a Delaware corporation, whose address is 17199 N. Laurel Park Drive, Suite 401, Livonia, Michigan 48152 (the "Company") and JEFFREY S. MATHIESEN whose address is as reflected in the personnel records of the Company ("Employee"). Capitalized terms used but not defined in this Agreement will have the meanings ascribed to them in the Employment Agreement between Employee and the Company dated April 14, 2016 (the "Employment Agreement").

Separation and Release Agreement (November 2nd, 2018)

This Separation and Release Agreement ("Release") is entered into by and between Differential Brands Group Inc., a Delaware corporation (the "Company") and Michael Buckley (the "Executive" or "I") (the Company and the Executive are collectively referred to as the "Parties") as of October 29, 2018 (the "Execution Date"). Capitalized terms used but not defined herein shall have the meaning set forth in the employment agreement between the Company and the Executive, dated January 28, 2016 (the "Employment Agreement"). Reference is made to that Purchase and Sale Agreement by and among Global Brands Group Holding Limited, GBG USA Inc., and the Company, dated as of June 27, 2018 (the "Purchase Agreement").

July 26, 2018 Brian Wiley Re: Separation and Release Agreement Dear Brian: (November 2nd, 2018)

This letter sets forth the terms of the separation agreement (the "Agreement") that NewLink Genetics Corporation (the "Company") is offering to aid in your employment transition.

Cempra Inc. – Separation and Release Agreement (October 5th, 2018)
Separation and Release Agreement (October 5th, 2018)

This Separation and Release Agreement (this "Agreement") is entered into by and between Core Molding Technologies, Inc. (the "Company") and Kevin Barnett ("Executive"). The Company and the Executive are referred to herein individually as a Party and collectively as the Parties.

Theravance – Separation and Release Agreement (October 4th, 2018)

This Separation and Release Agreement (this Agreement), delivered September 28, 2018, confirms the following understandings and agreements between Innoviva, Inc. (the Company) and George B. Abercrombie (hereinafter referred to as you or your).

Theravance – Separation and Release Agreement (October 4th, 2018)

This Separation and Release Agreement (this Agreement), delivered September 26, 2018, confirms the following understandings and agreements between Innoviva, Inc. (the Company) and Theodore J. Witek, Jr. (hereinafter referred to as you or your).

Separation and Release Agreement (August 27th, 2018)
Separation and Release Agreement (August 27th, 2018)
Separation and Release Agreement (August 27th, 2018)
Separation and Release Agreement (August 27th, 2018)
Separation and Release Agreement (August 27th, 2018)
Separation and Release Agreement (August 27th, 2018)
Destination Maternity – Separation and Release Agreement (August 14th, 2018)
Separation and Release Agreement (August 13th, 2018)

THIS SEPARATION AND RELEASE AGREEMENT ("Agreement") is made between Jerry D. Chase ("Employee") and BSQUARE CORPORATION ("Employer" or "BSQUARE"), and is in consideration of their mutual undertakings as set forth in this Agreement.

Theravance – Separation and Release Agreement (August 8th, 2018)

This Separation and Release Agreement (this Agreement), delivered August 8, 2018, confirms the following understandings and agreements between Innoviva, Inc. (the Company) and Eric dEsparbes (hereinafter referred to as you or your).

Re: Separation and Release Agreement (August 7th, 2018)

This letter sets forth the substance of the separation and release agreement (the "Agreement") that Ellie Mae, Inc. (the "Company") is offering to you to aid in your employment transition.

Nii Holdings – July 30, 2018 Re: Amended and Restated Separation and Release Agreement Dear Steve: (August 1st, 2018)

Pursuant to the Amended and Restated Separation and Release Agreement between you and NII Holdings, Inc. ("NII"), dated July 25, 2017 (the "Separation and Release Agreement"), NII agreed to provide certain benefits following your transition from Chief Executive Officer and Director to Director.

Cerecor Inc. – Separation and Release Agreement (July 16th, 2018)

This SEPARATION AND RELEASE AGREEMENT (the Agreement) is hereby made and entered into this 13th day of July 2018, by and between Cerecor Inc., a Delaware corporation (the Company), and Mariam Morris, a citizen and resident of Texas (Executive). (The Company and Executive are sometime referred to herein each as a Party and together as the Parties.)

Transition, Separation and Release Agreement (July 12th, 2018)

THIS TRANSITION, SEPARATION AND RELEASE AGREEMENT (this "Separation Agreement") dated as of July 12, 2018 is entered into by and between KEVIN BEAM ("Employee") and TECHTARGET, INC., a Delaware corporation, with an address at 275 Grove Street, Newton, MA 02466 ("Employer" or "Company"). Employee and Employer are hereinafter individually referred to as a "Party" and collectively as the "Parties."

NanoVibronix, Inc. – Separation and Release Agreement (July 10th, 2018)

This SEPARATION AND RELEASE ("Agreement"), dated July 4, 2018, is hereby made between Jona Zumeris ( D.Sc.), Israel ID No. ********* ( Jona), the founder of Nano-Vibronix Ltd. and VP technology officer , and Janina Zumeris , Israeli ID No. ********* ( Ina) , Parties of the First Part, and Nano- Vibronix (Israel 2003) Ltd. , a company registered in Israel (Israel Registration Number 513483164) (the "Israeli company") and its parent, NanoVibronix Inc. ., a publicly traded company registered in Delaware (the "US Company"), and its affiliated companies including predecessors, divisions, affiliates, subsidiaries, successors and assigns, (hereinafter together "Nano Vibronix" or the "Company") , Parties of the Second Part hereinafter referred to individually as a "Party" and collectively as the "Parties." This Agreement will become effective on the date it is executed by both Parties (the "Effective Date").